XML 53 R26.htm IDEA: XBRL DOCUMENT
v3.20.4

RESEARCH AND DEVELOPMENT EXPENSES | 12 Months Ended
--- | ---
Dec. 31, 2020
RESEARCH AND DEVELOPMENT EXPENSES. |
RESEARCH AND DEVELOPMENT EXPENSES | NOTE 21 - RESEARCH AND DEVELOPMENT EXPENSES:
|  | Year Ended December 31,
|  | 2020 |  | 2019 |  | 2018
|  | U.S. dollars in thousands
Payroll and related expenses |  | 636 |  | 623 |  | 552
Professional services and consulting fees |  | 1,752 |  | 2,345 |  | 2,297
Share-based payments |  | 883 |  | 671 |  | 872
Clinical and pre-clinical trials |  | 12,569 |  | 12,840 |  | 20,373
Intellectual property development |  | 298 |  | 317 |  | 290
Other |  | 353 |  | 623 |  | 478
|  | 16,491 |  | 17,419 |  | 24,862

X
- Definition The entire disclosure of research and development expense. + References No definition available. + Details
Name: | rdhl_DisclosureOfResearchAndDevelopmentExpenseTextBlock
Namespace Prefix: | rdhl_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition n/a + References No definition available. + Details
Name: | rdhl_IfrsResearchAndDevelopmentAbstract
Namespace Prefix: | rdhl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration